From 2008 to 2022, the incidence of cervical precancers fell by 80% among screened women aged 20 to 24 years, supporting ...

Moderna, Inc.'s stock soars 16% amid patent win over Pfizer/BioNTech, while legal battles highlight mRNA challenges. Click ...

A clinical trial demonstrates that personalised cancer vaccines effectively target mutations in high-risk kidney cancer, ...

Pancreatic cancer remains one of the most challenging tumors to treat, partly because it is often discovered at advanced ...

Senators challenged Jay Bhattacharya, MD, PhD, President Donald Trump's pick to lead the National Institutes of Health (NIH), ...

The S&P 500 advanced 1.1% on Wednesday, March 5, as the White House announced it would delay tariffs affecting U.S. automakers.

President Donald Trump’s pick to lead the National Institutes of Health answered sharp questions in a confirmation hearing ...

A University of Otago, Christchurch-led study is heralding the success of the HPV vaccination program, saying the cost and ...

New treatments for graft-vs.-host disease, updated dosage for HPV vaccines — and Fred Hutch announces awards for graduate students.

Moderna (MRNA) stock in focus as the company aims a 2027 marketing nod for Merck (MRK) partnered skin cancer vaccine. Read ...

Emily Yu, a longtime Beijing-based lingerie designer, has devoted some five years to developing bras and prostheses for women who have had a mastectomy - hoping her products will help them regain ...